title: A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly.
abstract: Chronic constipation is a common disorder in the general population, with higher prevalence in the elderly, and is associated with worse quality of life and with greater health care utilization. Lubiprostone is an intestinal type-2 chloride channel activator that increases intestinal fluid secretion, small intestinal transit, and stool passage. Lubiprostone is currently approved by the US Food and Drug Administration for the treatment of chronic idiopathic constipation and of irritable bowel syndrome with predominant constipation. This review outlines current approaches and limitations in the treatment of chronic constipation in the elderly and discusses the results, limitations, and applicability of randomized, controlled trials of lubiprostone that have been conducted in the general and elderly population, with additional focus on the use of lubiprostone in constipation in Parkinson's disease and in opioid-induced constipation, two clinical entities that can be comorbid in elderly patients.
authors: Gastroenterology Department, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
authors: Beatriz
authors: B
authors: Gras-Miralles
authors: Filippo
authors: F
authors: Cremonini
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D000527:Alprostadil / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000009:adverse effects; D002908:Chronic Disease; D003248:Constipation / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000453:epidemiology; D000068238:Lubiprostone; D008297:Male; D010300:Parkinson Disease / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic
chemical_list: D000701:Analgesics, Opioid; D000068238:Lubiprostone; D000527:Alprostadil
keywords: Parkinson’s disease; chronic constipation; irritable bowel syndrome; opioid-induced constipation